Earnings Call · Q2 FY2021·2021-08-05

Q2 21EPS +100.00%*·Rev n/aQ1 21EPS +61.76%·Rev n/aQ4 20EPS -22.58%·Rev n/aQ3 20EPS -100.00%*·Rev n/a⚠ consensus missing

PUMA BIOTECHNOLOGY, INC. PBYI

Mariann Ohanesian — Senior Director of Investor Relations

Alan Auerbach — Chief Executive Officer, President and Chairman of the Board

Jeffrey Ludwig — Head of Commercial or Commercial Lead

Maximo Nougues — Chief Financial Officer

+1.6%1d on move date+1.4% vs SPY3d+1.6%5d+4.1%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PBYI calls or request research access.

More PBYI calls Browse calls Request research access